Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Cancer Genes and Genomics

SINE Retrotransposons Cause Epigenetic Reprogramming of Adjacent Gene Promoters

Marcos R.H. Estécio, Juan Gallegos, Mhair Dekmezian, Yue Lu, Shoudan Liang and Jean-Pierre J. Issa
Marcos R.H. Estécio
Departments of 1Leukemia, 2Molecular Carcinogenesis, and 3Bioinformatics and Computational Biology, 4Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center; and 5Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
Departments of 1Leukemia, 2Molecular Carcinogenesis, and 3Bioinformatics and Computational Biology, 4Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center; and 5Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Gallegos
Departments of 1Leukemia, 2Molecular Carcinogenesis, and 3Bioinformatics and Computational Biology, 4Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center; and 5Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mhair Dekmezian
Departments of 1Leukemia, 2Molecular Carcinogenesis, and 3Bioinformatics and Computational Biology, 4Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center; and 5Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yue Lu
Departments of 1Leukemia, 2Molecular Carcinogenesis, and 3Bioinformatics and Computational Biology, 4Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center; and 5Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
Departments of 1Leukemia, 2Molecular Carcinogenesis, and 3Bioinformatics and Computational Biology, 4Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center; and 5Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shoudan Liang
Departments of 1Leukemia, 2Molecular Carcinogenesis, and 3Bioinformatics and Computational Biology, 4Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center; and 5Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
Departments of 1Leukemia, 2Molecular Carcinogenesis, and 3Bioinformatics and Computational Biology, 4Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center; and 5Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Pierre J. Issa
Departments of 1Leukemia, 2Molecular Carcinogenesis, and 3Bioinformatics and Computational Biology, 4Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center; and 5Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1541-7786.MCR-12-0351 Published October 2012
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Almost half of the human genome and as much as 40% of the mouse genome is composed of repetitive DNA sequences. The majority of these repeats are retrotransposons of the SINE and LINE families, and such repeats are generally repressed by epigenetic mechanisms. It has been proposed that these elements can act as methylation centers from which DNA methylation spreads into gene promoters in cancer. Contradictory to a methylation center function, we have found that retrotransposons are enriched near promoter CpG islands that stay methylation-free in cancer. Clearly, it is important to determine which influence, if any, these repetitive elements have on nearby gene promoters. Using an in vitro system, we confirm here that SINE B1 elements can influence the activity of downstream gene promoters, with acquisition of DNA methylation and loss of activating histone marks, thus resulting in a repressed state. SINE sequences themselves did not immediately acquire DNA methylation but were marked by H3K9me2 and H3K27me3. Moreover, our bisulfite sequencing data did not support that gain of DNA methylation in gene promoters occurred by methylation spreading from SINE B1 repeats. Genome-wide analysis of SINE repeats distribution showed that their enrichment is directly correlated with the presence of USF1, USF2, and CTCF binding, proteins with insulator function. In summary, our work supports the concept that SINE repeats interfere negatively with gene expression and that their presence near gene promoters is counter-selected, except when the promoter is protected by an insulator element. Mol Cancer Res; 10(10); 1332–42. ©2012 AACR.

This article is featured in Highlights of This Issue, p. 1241

Introduction

Retrotransposons of SINE and LINE classes have been extremely successful in colonizing mammalian genomes (1). Specifically in human and mouse, these 2 classes of repeats represent almost 50% of their genomes. This high frequency was in past regarded as a result of multiplication by retrotransposition and random integration into the genome. However, new evidences suggest that the current distribution of these elements was modeled by evolutionary constraints and that retrotransposons and other repeats have evolved from parasitic sequences into functional genomic elements (2, 3). Adding to these data, earlier evidences supported that the distribution of interspersed elements is conserved in the human and mouse genomes (4). The direct comparison of these genomes revealed a spatial concordance in positioning of SINE but not LINE repeats, indicating evolutionary pressure to maintain and/or exclude these repeats from orthologous regions (5).

Mobilization of retroelements is inhibited by epigenetic mechanisms (6). SINE and LINE elements are frequently methylated, as confirmed by the recent articles on genome-wide methylation studies in mouse and in human (7, 8). In normal cells, DNA methylation is rare in promoter-associated CpG islands but important to X-inactivation (9) and genomic imprinting (10). During tumorigenesis, hundreds to thousands of genes gain methylation in promoter-associated CpG islands, affecting many pathways including tumor suppressor pathways (11). The causes of this massive switch in DNA methylation remain mysterious. When searching for sequences that differentiate genes that are rarely methylated in cancer from those frequently methylated, we found that SINE and LINE retrotransposons are enriched around the transcription start sites (TSS) of genes that are never or rarely methylated in cancer (12). Such association was so strong that it was possible to build a mathematical model to predict gene methylation based on the presence of retrotransposons near the genes TSS, and this model worked well when applied to methylation data from both cancer cell lines and primary tissues. Similar findings supporting that a signature of retrotransposon abundance predicts epigenetic states have been described for DNA methylation in normal tissues (13), DNA methylation in cancer (14), genomic imprinting (15), and X-Aprtchromosome inactivation (16), among other studies. Given the hypermethylated state of retrotransposons in normal cells, it is somewhat paradoxical that SINE and LINE elements are poorly represented in the vicinity of genes that become hypermethylated in cancer (12, 14, 17). Moreover, SINE B1 elements were previously reported to cause transcriptional silencing of the adjacent Aprt gene by spreading of DNA methylation (18).

We hypothesized that the enrichment of retrotransposons near cancer methylation–resistant genes is due to a negative influence of SINE repeats on gene expression and counter selection over evolution, resulting in exclusion of these repeats from vulnerable genomic environments. Thus, only gene promoters with intrinsic resistance to DNA methylation are permissive to the nearby presence of retrotransposons. This hypothesis predicts that (i) SINE retrotransposons cause silencing of vulnerable nearby gene promoters and (ii) SINE abundance near promoters correlates with genomic features that limit retrotransposons influence on adjacent chromatin. Here, we show that both of these predictions are correct.

Materials and Methods

Cell lines, plasmids, and transfection

Promoter regions containing CpG islands from murine genes Cdkn2d (−440 to +618 bp from the gene TSS), Cdkn2a long transcript, also known as p14Arf (−273 to +474 bp from the gene TSS), and Mlh1 (−226 to +267 bp from the gene TSS) were identified from mouse genome sequence repositories and amplified by PCR. The rationale for selecting these genes among thousands of others with a promoter CpG island was that p14Arf and Mlh1 have tumorigenic potential in mice and that their human homologues are prone to become hypermethylated in human neoplasias (19, 20). Cdkn2d was included because it belongs to the same gene family as that of p14Arf. Also, none of these promoter CpG islands are constitutively methylated in normal cells. NIH/3T3 DNA was used as template to Cdkn2d and Mlh1 PCR, and p14Arf was amplified from BALB/c mice liver DNA. The PCR fragments were digested by appropriate restriction enzymes and subcloned into a pGL3-Basic reporter plasmid (wild-type promoters). SINE B1 elements were inserted immediately upstream to cloned promoters, generating the plasmid variants containing 2, 4, or 6 B1 elements (see Supplementary Table S1 for more details on the cloned SINE B1s and other repetitive elements used in this study). Mouse embryonic fibroblast NIH/3T3 cells were transiently cotransfected with the promoter constructs (1 μg) and 20 ng of pRL-TK vector using FuGene reagent (Roche) according to standard methods. Cells were harvested approximately 24, 48, and 72 hours after transfection, and luciferase activity from cell extracts was detected using the Luciferase Assay System (Promega) as specified by the manufacturer. The magnitude of activation of luciferase constructs was determined after normalization to pRL-TK activity, and the value of each wild-type promoter was then taken as 1.0-fold. Stable transfections were conducted by cotransfection of a neomycin expression vector. Neomycin selection was initiated on day 2 after transfection, the medium was replaced with fresh Dulbeccos' Modified Eagles' Media (DMEM) containing 10% calf serum and G418 at 400 μg/mL (Invitrogen), and the cells were subcultured every 2 to 3 days. Cell pellets were collected for DNA extraction and luciferase readings at days 19, 36, 48, 60, and 90 for Cdkn2d and Mlh1 constructs and days 15, 22, 29, 36, 43, and 50 for p14Arf constructs. Sequences of all primers used in this work are provided in Supplementary Table S2. For investigation of human SINEs, we cloned the human CDH1 gene promoter upstream to the luciferase reporter gene in 4 different configurations: wt-CDH1, without any retroelements (−303 to +1,370 bp from the gene TSS); SINE-CDH1, with Alu and Mir sequences downstream to the gene promoter (−303 to +2,318 bp from the gene TSS); LINE-CDH1, with a LINE element sequence downstream to the gene promoter cloned in the position +836 bp from the gene TSS in the wt-CDH1 plasmid; and (S/L)INE-CDH1, with Alu, Mir, and LINE sequences downstream to the promoter (see Fig. 6A for a graphic representation of these constructs). Luciferase activity of the transgenes was measure as described above after transient transfection in the human cell lines RKO (colorectal carcinoma) and NCI-H1299 (lung carcinoma). All cell lines were obtained directly from American Type Culture Collection. These cell lines were not re-authenticated in our laboratory since the vendor already authenticated them.

DNA methylation studies

Bisulfite treatment was conducted as previously reported (21), and one tenth of the final volume was used as a template for PCR. Except for p14Arf (which is deleted in NIH/3T3 cells), the other gene promoters were amplified by semi-nested PCRs, where one of the primers of the first reaction was located in the plasmid sequence to avoid detection of the endogenous gene. Methylation density was determined by COBRA [combined bisulfite restriction analysis (ref. 22)]; PCR products were separated by 6% PAGE and stained with ethidium bromide, imaged, and quantitated in a Bio-Rad Geldoc 2000 imager (Bio-Rad), and the methylation density for each sample was computed as a ratio of the density of the digested band to the density of all bands in a given lane. DNA methylation was confirmed by bisulfite sequencing and/or pyroMeth analysis. The full list of primers used in these studies is presented in Supplementary Table S2.

Chromatin immunoprecipitation assays

Log-phase growing cells were cross-linked with 1% formaldehyde, washed twice with cold PBS with protease inhibitors, and harvested by scrapping. Cells were sonicated in SDS lysis buffer, followed by elution in chromatin immunoprecipitation (ChIP) buffer. We selected to evaluate promoter marking by active histone modifications that are universally observed in active promoters (H3K9ac) or preferentially found in active promoter CpG islands (H3K4me3) and that are associated with gene repression at the same time or not that DNA methylation (H3K9me2) or typically mutually exclusive to DNA methylation (H3K27me3). The following antibodies were used for immunoprecipitation: H3K4me3 (Millipore, 17-614), H3K9ac (Millipore, 07-352), H3K9me2 (Abcam, ab1220), H3K27me3 (Millipore, 17-622), histone H3 (Abcam, ab1791-100), and rabbit IgG (Abcam, ab46540). Chromatin–antibody complexes were captured using Dynabeads Protein A/G (Invitrogen), and the immunoprecipitated DNA was treated with proteinase K, purified by column filtration, and eluted in Tris-buffer. Quantitative real-time PCR was used to detect amplicons from the target sequences (p14Arf promoter and SINE B1) and positive controls of active (Tuba1a) and repressed genes (Hbb-b1 and Nanog), and the fold enrichment of each histone modification and rabbit IgG to histone H3 was calculated using the ΔCt method.

Genome-wide mapping of SINE and LINE repeats

TSS coordinates of mouse and human RefSeq genes and SINE repeats were downloaded from the UCSC Genome Browser (mm8 and hg18 releases). The coordinates of binding sites of CTCF in the human genome are available from public data releases from the Encode Chromatin Group at Broad Institute and Massachusetts General Hospital (Boston, MA), and mouse CTCF-binding sites were reported (23). Genome coordinates of USF1 and USF2 binding were available from the work of Rada-Iglesias and colleagues (24). Each RefSeq gene was represented by 20 bins of 1-kb sequence each (10 bins upstream and 10 bins downstream of gene TSS), and each bin was then annotated as occupied or not by SINE retrotransposons (when falling in between bins, SINEs were annotated to the closest bin to TSS). We compared the average abundance of SINE retrotransposons per bin in gene bound and not bound by each CTCF, USF1, and USF2 in the 20-kb genomic region around gene TSS. Genes were also classified as having or not a CpG island overlapping with their proximal promoter regions (−200 to +200 bp). The frequency distribution of SINEs in the 2 groups (genes bound and not bound by insulator proteins) was compared using the Student t test.

Results

SINE B1 elements reduce the transcriptional activity of adjacent promoters

To test the capacity of SINE B1 elements in promoting gene silencing, we generated a system where the luciferase gene is under the control of 3 different mouse gene promoters (Cdkn2d, p14Arf, and Mlh1), and we inserted 2 and 4 copies of SINE B1 elements upstream to these promoters (Fig. 1A; all primers used in this study are included in Supplementary Table S2). One plasmid containing 6 copies of SINE B1 elements (6B1-p14Arf) was also used in some of the experiments. These plasmids were transfected in the immortalized mouse fibroblast cell line NIH/3T3 (more details in Materials and Methods). This cell line was chosen for our experiments because it showed the capacity to sustain DNA methylation in transfected plasmids (25) and also due to its high efficiency of transfection. We initially assayed luciferase activity after short-term transfection, and we observed that the plasmids with SINE B1 elements were 30% to 60% less transcriptionally active than plasmids without SINE B1 insertion (Fig. 1B–D). The level of repression was dependent on the number of copies of inserted SINE elements, and we found that the repression increased with time. Transcriptional repression was independent of the orientation of SINE B1 elements, as these retrotransposons caused the same degree of repression when they were inserted in negative orientation to the gene promoter (Supplementary Fig. S1).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Gene promoters with nearby SINE B1 show reduced transcriptional activity. A, plasmid constructs used to evaluate the effect of SINE B1 elements on promoter activity. The luciferase reporter gene was put under the control of mouse Cdkn2d, Mlh1 or p14Arf promoter, and SINE B1 elements were inserted in tandem 2 or 4 times immediately upstream to these promoters. B1a and B1b denote individual sequences with 19.2% and 4.9% divergence from the consensus SINE B1, respectively. Transcriptional activity of (b) Cdkn2d, (c) Mlh1, and (d) p14Arf promoters without (wt) and with SINE B1 insertions (2B1 and 4B1) in mouse NIH/3T3 after transient transfection. The measured luciferase activity was reduced in SINE B1–containing plasmids compared with wt.

p14Arf is silenced by SINE B1s and shows characteristic repressed chromatin

We followed the dynamics of promoter activity over time during a 2-month period, and we found that the p14Arf plasmids with SINE B1 insertion become fully repressed (Fig. 2A). The repression of the p14Arf promoter activity was reproducible in 2 independent experiments, ruling out possible effects related to plasmid insertion sites in the genome. Notably, the loss in promoter activity occurred in a temporal fashion, suggesting that reinforcing mechanisms act to promote gene repression. To evaluate whether epigenetic reprogramming had occurred, DNA methylation density near the TSS of p14Arf was measured using the COBRA assay (22). No special considerations for primer design were required to avoid investigation of an endogenous copy of p14Arf because this gene is homozygously deleted in NIH/3T3 cells. We observed that after an initial gain of methylation in the p14Arf promoter by day 29, no significant difference was observed afterward (Fig. 2B), despite consistent transcriptional repression. The methylation data at day 29 were confirmed by pyroMeth, showing that the gain of methylation was not restricted to an individual CpG site but was concordant between 9 individual CpG sites located between the positions −21 and +88 base pairs from the gene TSS (Fig. 2C). We hypothesized that for p14Arf the DNA methylation mark was replaced by other epigenetic mechanisms of silencing, most likely histone marking. Indeed, using ChIP assays, we found that the p14Arf promoter showed a large enrichment for H3K4me3 and H3K9ac in p14Arf-wt compared with 4B1-p14Arf plasmids. However, the repressive marks H3K9me2 and H3K27me3 did not differ significantly (Fig. 2D), suggesting that other marks are relevant here. In summary, the presence of SINE B1 elements near gene TSS promoted epigenetic reprogramming with changes in DNA methylation and histone posttranslational modifications.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

SINE B1 elements cause transcriptional repression and epigenetic reprogramming of the p14Arf gene promoter. A, promoter activity over time with and without proximal insertion of SINE B1 elements. The p14Arf promoter shows gradual decline in promoter activity only when SINE B1s are present. The results of 2 independent experiments are shown. Luciferase units were normalized by total protein in cell lysates. b, de novo methylation of gene promoter. Compatible with the decrease in activity, the promoter of p14Arf shows increased DNA methylation when SINE B1 elements are present. The methylation measurement was done by COBRA; the lower molecular weight band is resultant of cleavage of DNA when an internal CpG site to a selected restriction enzyme recognition site is maintained after bisulfite treatment, thus present only in amplicons originated from a methylated template. SssI is a positive control for presence of methylation and was generated by treating the plasmid DNA with the SssI methylase enzyme. Vector DNA is used as negative control of methylation. C, pyrograms showing the methylation status of CpG sites at positions +79 to +88 bp from TSS of the p14Arf promoter, 29 days after stable transfection in NIH/3T3 cells. PyroMeth is a highly quantitative method with better accuracy than bisulfite sequencing and COBRA. Note that 4B1-p14Arf and 6B1-p14Arf are hypermethylated, whereas wt-p14Arf and 2B1-p14Arf show low levels of DNA methylation. A graphic representation of pyroMeth analysis of 9 CpG sites from positions −21 to +88 bp from TSS of the p14Arf promoter measured at 29 days after stable transfection is shown in the bottom. D, switch of epigenetic marking. After initial strong DNA methylation, the p14Arf promoter with proximal SINE B1 elements lost this mark but stayed in a closed chromatin configuration, as indicated by the lack of H3K4me3 and H3K9ac as measured by ChIP assays.

Cdkn2d is also silenced by SINE B1s while the Mlh1 gene promoter is refractory to SINE-mediated silencing

We also studied the long-term effects of SINE B1s in Cdkn2d and Mlh1 promoter activity. Consistent with a role of SINE B1s as repressors, the Cdkn2d promoter gradually lost activity until reaching only 5% to 10% of its original strength when cloned close to B1 sequences (Fig. 3A). In a sharp contrast to p14Arf, there was a progressive and persistent gain of methylation in the Cdkn2d promoter in B1-containing plasmids (Fig. 3B). An exception to continued silencing by SINE B1s was seen for Mlh1 plasmids (Fig. 3C). Despite the decrease in promoter activity of Mlh1 promoter in B1-containing plasmids in short-term transfections, no additional repression was measured afterward. Inverting the direction of the Mlh1 promoter did not change this result in an independent experiment. These differences between p14Arf, Cdkn2d, and Mlh1 in response to SINE-B1s in long-term transfections are also supported by the non-normalized data (Supplementary Fig. S2). The Mlh1 promoter remained mostly unmethylated in both wt- and B1-containing plasmids, in agreement with lack of change in promoter activity as measured by luciferase activity (Fig. 3D). Bisulfite sequencing of the Mlh1 promoter region confirmed that the CpG sites close to the TSS were resistant to de novo methylation (Fig. 3E and F) but the remaining CpG sites elsewhere gained methylation. However, this gain in methylation did not differ between wt- and B1 plasmids, suggesting that it occurred stochastically.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Mlh1 is refractory to silencing by SINE B1s. A, as observed for p14Arf, the Cdkn2d promoter was sensitive to the presence of SINE B1s and showed gradual decline in promoter activity along time but relatively stable activity when cloned in a B1-free reporter vector. B, increased DNA methylation density of the Cdkn2d promoter is correlated with the repression by SINE B1s. The gel image was captured as described in the Materials and Methods from a COBRA experiment. SssI is a positive control for presence of methylation and was generated by treating the plasmid DNA with the SssI methylase enzyme. Vector DNA is used as negative control of methylation. C, Mlh1 promoter is resistant to transcriptional silencing by SINE B1 retrotransposons. The Mlh1 promoter did not show an additional loss in promoter activity when cloned close to B1 elements, as measured by the luciferase assay. We inverted the direction of the Mlh1 promoter in the pGL3-basic plasmid (bottom) to test whether the resistance to silencing by SINE B1 retrotransposons was dependent on its orientation. Similarly to the Mlh1 promoter cloned in positive orientation (i.e., the intronic region close to the luciferase gene), the Mlh1 promoter cloned in negative orientation with nearby B1 insertions did not show lower levels of expression compared with the retrotransposon-free plasmids. D, in concordance with the maintained active status of the Mlh1 promoter, there was no gain in DNA methylation near the gene TSS as measured by COBRA. E, bisulfite sequencing of the Mlh1 promoter confirmed that the 4B1-Mlh1 plasmids did not gain methylation more rapidly than the wt-Mlh1 plasmids. Black circles represent methylated cytosines in a CpG dinucleotide and empty circles are unmethylated cytosines. F, the average methylation of each region of the bisulfate-sequenced Mlh1 sequence [upstream to TSS, 5′ untranslated region (UTR), coding region of the exon 1 and intron 1] is shown in the bottom. Data from 90 days after transfection of both wt-Mlh1 and 4B1-Mlh1 were averaged. The 5′ UTR is resistant to de novo methylation, compared with the other regions.

A cryptic methylation center upstream to p14Arf TSS is destabilized by SINE B1s

An important question is whether the SINE B1s are acting as methylation centers in this system, as reported previously for the mouse Aprt gene. To address this question, we conducted bisulfite sequencing to gain deeper information about methylation changes in the p14Arf promoter. The pattern of methylation was consistent with the data generated by COBRA and pyroMeth, with higher overall methylation of B1-containing plasmids (Fig. 4A). Two additional pieces of information were generated in this experiment. First, the pattern of methylation was not consistent with methylation spreading from B1 elements into nearby DNA, as the promoter sequence adjacent to SINE B1 remained mostly unmethylated. We observed, however, the existence of internal sequences in the p14Arf promoter that gained methylation before other CpG sites and methylation spreading from these regions, which we call here a cryptic methylation center. Interestingly, the alignment of the 4 central CpG sites in the cryptic methylation center revealed a repeated sequence motif (A/G)GCG(A/G)(A/G), but no protein is known or predicted to bind to this site. Although also present in wt-p14, these regions gained methylation more rapidly in B1-containing plasmids. Second, as observed for the Mlh1 promoter, the CpG sites away from the TSS are more susceptible to gain of methylation (Fig. 4B), accumulating methylation density as high as 90% (for the methylation center) and 35% (the region upstream to the TSS).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

The p14Arf promoter has a cryptic methylation center. A, four CpG sites in the p14Arf promoters gained methylation at a faster rate than other CpG sites at 22 days after transfection, and spreading of DNA methylation can be observed in the vicinity of these sites at days 36 and 50. The absence of methylation in the most 5′ CpG sites suggests that SINE B1 repeats did not function as methylation centers, and it is confirmed in Fig. 5A. Black circles represent methylated cytosines in a CpG dinucleotideand empty circles are unmethylated cytosines. Each row of circles is an individual plasmid. B, average methylation per region. The p14Arf promoter was divided in 4 regions: the TSS + exon, from the TSS to the end of the exon 1 according to the annotated gene CDS; methylation center, the region that first gained methylation in both wt- and B1-containing plasmids; upstream to TSS and 5′ distal, representing the portion of the sequenced region between the TSS + exon 1 and the methylation center, and upstream to the methylation center, respectively. Methylation density is shown for each of these for regions as measured on days 22, 36 and 50 by bisulfite sequencing.

Cloned SINE B1s did not become methylated but acquired a silent chromatin configuration

To better characterize the epigenetic status of the SINE B1 elements, we conducted bisulfite sequencing of the most 5′ region of the p14Arf promoter together with 2 or 4 copies of SINE B1s. This sequencing of B1 elements in p14Arf plasmids revealed that they remained methylation-free, supporting the idea that in this system, these elements do not function as centers for spreading of DNA methylation (Fig. 5A). B1 elements, however, acquired H3K9me2 and H3K27me3, both markings associated with repressed status (Fig. 5B) as revealed by ChIP assay in comparison with the physiologically repressed genes Hbb-b1 and Nanog and the constitutively expressed Tuba1a gene.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

SINE B1 elements remained methylation-free and do not function as methylation centers in this system. A, bisulfite sequencing of B1 sequences upstream to the p14Arf promoter shows no sign of significant cytosine methylation of these elements. B, despite their DNA methylation–free status, SINE B1s (p14Arf-B1 columns) are targeted by chromatin remodeling complexes and become marked by H3K9me2 and H3K27me3. Tuba1a is an active gene and was used as positive control for H3K4me3 and H3K9ac; Hbb-b1 and Nanog are repressed in mouse NIH/3T3 cells and were used as positive controls for H3K9me2 and H3K27me3.

Human Alu SINEs also trigger rapid gene repression

Because mouse SINE B1 elements caused transcriptional repression, we sought to investigate whether human SINE and LINE repeats could have the same effect. For this study, we used the human E-cadherin gene (CDH1) as a model (Fig. 6A). The human CDH1 gene has 4 SINEs adjacent to the 3′ region of its CpG island (3 Alus and a Mir element), and in reporter assays, the removal of these repeats resulted in higher, stable promoter activity in a cell line–dependent manner (Fig. 6B). However, the introduction of LINE sequence to plasmids with or without SINEs did not change promoter activity. Thus, SINE retrotransposons of human origin, similar to the tested mouse SINE, can interfere negatively with promoter activity.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

The human CDH1 gene promoter is sensitive to SINE, but not LINE retrotransposons. A, cloning strategy of the CDH1 gene promoter in the pGL3-basic vectors, with and without SINE and LINE retrotransposons. As shown, different constructs were transiently transfected in RKO (colon cancer cell line) and NCI-H1299 (lung cancer cell line). Promoter activity of different CDH1 constructs 36 hours after transfection. Similar to mouse B1 elements, human Alu (a) and Mir retrotransposons (m) were associated with lower transcriptional activity of the CDH1 gene promoter in (B) RKO cells, whereas LINE sequence (L2) did not cause change in gene expression. This pattern was not reproducible in (C) NCI-H1299 cells, suggesting that cellular mechanisms interfere with the capacity of SINEs in promoting gene repression.

Retrotransposon distribution is influenced by insulator elements

To investigate the second prediction derived from our hypothesis, that is, that SINE fitness is influenced by insulator elements, we annotated the abundance of mouse and human SINE retrotransposons in a 20-kb genomic region around genes TSS and then compared the frequency of these elements between genes bound and not bound by CTCF, USF1, and USF2 (Fig. 7). These transcription factors have been previously proven to function as barriers to heterochromatin spreading (26, 27), and data of their in vivo binding in mouse embryonic stem cells (23) and multiple normal cell lines are available from whole-genome maps (24) and in public releases from the Encode Chromatin Group at Broad Institute and Massachusetts General Hospital. Other putative insulators such as SP1 (25, 28) and VEZF1 (29) were not tested because they lack extensive in vivo binding studies, and we excluded from our study predicted binding sites. In general, genes bound by any of these factors show a higher frequency of SINE repeats than unbound genes, and the observed difference is statistically significant (P < 0.01, t test). An exception is that the distribution of Alu repeats between CTCF-bound and -unbound genes is similar in promoter CpG islands (but different in non-CpG island promoters). This finding was concordant between mouse and human genomes, and we believe that the lack of difference is related to the high frequency of CTCF-binding sites in CpG islands (40% of promoter CGI are bound by CTCF, compared with 20% in non-CpG island promoters), a weaker insulating activity of CTCF than USF1 and USF2, and that CpG islands are maintained in open chromatin status by additional mechanisms (e.g., binding of Cfp1 and KDM2A proteins; refs. 30, 31). USF1 and USF2 were similarly distributed between promoter CGI and non-CGI (USF1 and USF2 are present in 7% and 5% of gene promoters, respectively). In conclusion, the presence of SINE repeats is better tolerated by gene promoters insulated through USF1, USF2, and CTCF (in the case of non-CpG island promoters).

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

SINE retrotransposons accumulate near gene promoters bound by insulator proteins. Gene promoters were grouped according their overlap with CpG islands (CGI) and binding by CTCF (mouse and human promoters), USF1 and USF2 (human promoters only). The graphics show the frequency of SINE repeats in a 20-kb window centered in genes TSS. Except for promoters CGI bound by CTCF, the presence of an insulator created an environment that is more permissive to SINE repeats than insulator-free promoters.

Discussion

Here, we show that SINE B1 elements can influence the activity of proximal promoters and ultimately lead to epigenetic reprogramming. The early effect on promoter activity is compatible with direct recruitment of co-repressors; however, alternative mechanisms cannot be ruled out. Independent of the mechanism by which SINE elements promote transcriptional repression with associated epigenetic remodeling of adjacent promoters, it is evident that their close proximity to gene promoters has a deleterious effect and, as such, their insertion in close proximity to gene promoters is evolutionary constrained. Indeed, we show here that Alu repeats in the human genome are more frequently found near gene promoters that are bound by insulator proteins. In addition, our results show that for the tested gene promoters, transcriptional repression occurred before DNA methylation, supporting previous findings in a different cellular system (32). In the case of Cdkn2d promoter, transcriptional repression was sufficient to trigger relatively stable DNA methylation. A more dynamic mechanism of repression was involved in p14Arf silencing, with DNA methylation being subsequently replaced by histone marking. A similar phenomenon has been observed in cancer cells and dubbed “epigenetic switch,” however, in that case, repressive histone markings were replaced by DNA methylation (33, 34). It is clear from our results that not all genes are equally sensitive to repression by retrotransposons, as Mlh1 promoter activity was only moderately affected by B1 SINEs: Despite an initial decrease in promoter activity very early after transfection, no additional effect is observed later on. We speculate that the proximal promoter of Mlh1 is protected from heterochromatinization; indeed, profiling of multiple cancer tissues has shown that Mlh1 is methylated in a lower fraction of tumors compared with other classically studied genes such as p16 and DAPK1.

Our data add to previous reports where silencing of nearby genes was induced by a retrotransposon. As we mentioned earlier, mouse B1 elements were reported to act as methylation centers from where DNA methylation leaked into the Aprt gene promoter (18). Our data differ from this reporter in that spreading of DNA methylation from the SINE B1 into the nearby gene promoters was not observed. Still, this retroelement mediated gene repression and facilitated methylation spreading from a cryptic methylation center located in the proximal promoter of the p14Arf gene. A possible explanation for this difference is that hundreds of thousands of SINE B1 elements occur in mice, and it is likely that different subfamilies exert their influence in nearby sequences through alternative mechanisms. For example, a subfamily of B1 elements has been previously described, and its influence on the transcriptional activity of proximal genes is mediated by the transcription factors Ahr and Slug (35). It still remains to be fully understood the primordial role that this newly identified SINE B1 subfamily plays in the genome, as the same research group later described an insulator function for this element (36). Such apparently contradictory findings show the complexity of the issue in question, with alternative outcomes of SINE B1 presence being mediated by sequence variation, physical localization in the genome and potentially tissue-specific regulation. Lunyak and colleagues (37) have identified an insulator activity for another SINE family, SINE B2. In their study, the insulating activity of SINE B2 elements appeared to be tissue-specific, as it created a permissive chromatin state for the transcription of the pituitary-specific growth hormone gene, and also developmentally regulated. Altogether, these data point out that it is unlikely that all retroelements of a certain family will have a universal function. Subtle changes in sequence and location in the genome, which creates an opportunity for interaction with diverse regulatory elements, will ultimately model their activity.

A weakness of our study is that our system is based on random integration of plasmids. Thus, we cannot rule out site-specific effects that may influence the SINE B1 activity and the transcriptional outcome of the tested gene promoters. However, it appears that site-specific effects were not the major determinants of the transcriptional and epigenetic fate of the tested constructs, given the reproducibility of the data across different gene promoters and between repeated experiments. In addition, the observed correlation of SINE elements in both human and mouse genomes with known insulator factors suggests that by large, there is a need for isolating genes from these elements. Recent reports revealed that retrotransposition occurs in relatively high levels and account for genome variability across individuals and normal to disease states (38–41). Once enough data have been generate with correlated genome, epigenome, and transcriptome information for multiple subjects, it will be possible to more directly access the effect of newly inserted elements on the transcription and epigenetic state of neighboring genes. Naturally, hundreds to thousands of observations will be necessary to distinguish noise from an actual effect.

Disclosure of Potential Conflicts of Interest

J.-P. J. Issa is an American Cancer Society Professor. No potential conflicts of interest were disclosed.

Authors' Contributions

Conception and design: M.R.H. Estécio, J.-P. J. Issa

Development of methodology: M.R.H. Estécio, J.-P. J. Issa

Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): M. Dekmezian

Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): M.R.H. Estécio, J. Gallegos, M. Dekmezian, Y. Lu, S. Liang, J.-P. J. Issa

Writing, review, and/or revision of the manuscript: M.R.H. Estécio, J.-P. J. Issa

Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): M. Dekmezian

Study supervision: S. Liang, J.-P. J. Issa

Grant Support

This work was supported by NIH grants P50CA100632, RO1CA098006, and R33CA89837. All DNA sequencing was conducted in the DNA Analysis Core Facility at the M.D. Anderson Cancer Center, which is supported by NCI Grant CA-16672 (DAF).

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Footnotes

  • Note: Supplementary data for this article are available at Molecular Cancer Research Online (http://mcr.aacrjournals.org/).

  • Received June 22, 2012.
  • Revision received July 27, 2012.
  • Accepted August 22, 2012.
  • ©2012 American Association for Cancer Research.

References

  1. 1.↵
    1. Kazazian HH Jr.
    . Mobile elements: drivers of genome evolution. Science 2004;303:1626–32.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Faulkner GJ,
    2. Kimura Y,
    3. Daub CO,
    4. Wani S,
    5. Plessy C,
    6. Irvine KM,
    7. et al.
    The regulated retrotransposon transcriptome of mammalian cells. Nat Genet 2009;41:563–71.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Shen S,
    2. Lin L,
    3. Cai JJ,
    4. Jiang P,
    5. Kenkel EJ,
    6. Stroik MR,
    7. et al.
    Widespread establishment and regulatory impact of Alu exons in human genes. Proc Natl Acad Sci U S A 2011;108:2837–42.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Soriano P,
    2. Meunier-Rotival M,
    3. Bernardi G
    . The distribution of interspersed repeats is nonuniform and conserved in the mouse and human genomes. Proc Natl Acad Sci U S A 1983;80:1816–20.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Bernardi G,
    2. Waterston RH,
    3. Lindblad-Toh K,
    4. Birney E,
    5. Rogers J,
    6. Abril JF,
    7. et al.
    Initial sequencing and comparative analysis of the mouse genome. Nature 2002;420:520–62.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Walsh CP,
    2. Chaillet JR,
    3. Bestor TH
    . Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nat Genet 1998;20:116–7.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Lister R,
    2. Pelizzola M,
    3. Dowen RH,
    4. Hawkins RD,
    5. Hon G,
    6. Tonti-Filippini J,
    7. et al.
    Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009;462:315–22.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Meissner A,
    2. Mikkelsen TS,
    3. Gu H,
    4. Wernig M,
    5. Hanna J,
    6. Sivachenko A,
    7. et al.
    Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008;454:766–70.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Heard E,
    2. Clerc P,
    3. Avner P
    . X-chromosome inactivation in mammals. Annu Rev Genet 1997;31:571–610.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Barlow DP
    . Gametic imprinting in mammals. Science 1995;270:1610–3.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Jones PA,
    2. Baylin SB
    . The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415–28.
    OpenUrlPubMed
  12. 12.↵
    1. Estecio MR,
    2. Gallegos J,
    3. Vallot C,
    4. Castoro RJ,
    5. Chung W,
    6. Maegawa S,
    7. et al.
    Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res 2010;20:1369–82.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Bock C,
    2. Paulsen M,
    3. Tierling S,
    4. Mikeska T,
    5. Lengauer T,
    6. Walter J,
    7. et al.
    CpG island methylation in human lymphocytes is highly correlated with DNA sequence, repeats, and predicted DNA structure. PLoS Genet 2006;2:e26.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Feltus FA,
    2. Lee EK,
    3. Costello JF,
    4. Plass C,
    5. Vertino PM
    . DNA motifs associated with aberrant CpG island methylation. Genomics 2006;87:572–9.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Greally JM
    . Short interspersed transposable elements (SINEs) are excluded from imprinted regions in the human genome. Proc Natl Acad Sci U S A 2002;99:327–32.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Wang Z,
    2. Willard HF,
    3. Mukherjee S,
    4. Furey TS
    . Evidence of influence of genomic DNA sequence on human X chromosome inactivation. PLoS Comput Biol 2006;2:e113.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Feltus FA,
    2. Lee EK,
    3. Costello JF,
    4. Plass C,
    5. Vertino PM
    . Predicting aberrant CpG island methylation. Proc Natl Acad Sci U S A 2003;100:12253–8.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Yates PA,
    2. Burman R,
    3. Simpson J,
    4. Ponomoreva ON,
    5. Thayer MJ,
    6. Turker MS,
    7. et al.
    Silencing of mouse Aprt is a gradual process in differentiated cells. Mol Cell Biol 2003;23:4461–70.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Fu Z,
    2. Regan K,
    3. Zhang L,
    4. Muders MH,
    5. Thibodeau SN,
    6. French A,
    7. et al.
    Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice. J Clin Invest 2009;119:2714–24.
    OpenUrlPubMed
  20. 20.↵
    1. Kamijo T,
    2. Zindy F,
    3. Roussel MF,
    4. Quelle DE,
    5. Downing JR,
    6. Ashmun RA,
    7. et al.
    Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997;91:649–59.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Toyota M,
    2. Ho C,
    3. Ahuja N,
    4. Jair KW,
    5. Li Q,
    6. Ohe-Toyota M,
    7. et al.
    Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 1999;59:2307–12.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Xiong Z,
    2. Laird PW
    . COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997;25:2532–4.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Chen X,
    2. Xu H,
    3. Yuan P,
    4. Fang F,
    5. Huss M,
    6. Vega VB,
    7. et al.
    Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008;133:1106–17.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Rada-Iglesias A,
    2. Ameur A,
    3. Kapranov P,
    4. Enroth S,
    5. Komorowski J,
    6. Gingeras TR,
    7. et al.
    Whole-genome maps of USF1 and USF2 binding and histone H3 acetylation reveal new aspects of promoter structure and candidate genes for common human disorders. Genome Res 2008;18:380–92.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Boumber YA,
    2. Kondo Y,
    3. Chen X,
    4. Shen L,
    5. Guo Y,
    6. Tellez C,
    7. et al.
    An Sp1/Sp3 binding polymorphism confers methylation protection. PLoS Genet 2008;4:e1000162.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Bell AC,
    2. West AG,
    3. Felsenfeld G
    . The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell 1999;98:387–96.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. West AG,
    2. Huang S,
    3. Gaszner M,
    4. Litt MD,
    5. Felsenfeld G
    . Recruitment of histone modifications by USF proteins at a vertebrate barrier element. Mol Cell 2004;16:453–63.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Mummaneni P,
    2. Yates P,
    3. Simpson J,
    4. Rose J,
    5. Turker MS
    . The primary function of a redundant Sp1 binding site in the mouse aprt gene promoter is to block epigenetic gene inactivation. Nucleic Acids Res 1998;26:5163–9.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Dickson J,
    2. Gowher H,
    3. Strogantsev R,
    4. Gaszner M,
    5. Hair A,
    6. Felsenfeld G,
    7. et al.
    VEZF1 elements mediate protection from DNA methylation. PLoS Genet 2010;6:e1000804.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Blackledge NP,
    2. Zhou JC,
    3. Tolstorukov MY,
    4. Farcas AM,
    5. Park PJ,
    6. Klose RJ,
    7. et al.
    CpG islands recruit a histone H3 lysine 36 demethylase. Mol Cell 2010;38:179–90.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Thomson JP,
    2. Skene PJ,
    3. Selfridge J,
    4. Clouaire T,
    5. Guy J,
    6. Webb S,
    7. et al.
    CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 2010;464:1082–6.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Mutskov V,
    2. Felsenfeld G
    . Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J 2004;23:138–49.
    OpenUrlAbstract
  33. 33.↵
    1. Gal-Yam EN,
    2. Egger G,
    3. Iniguez L,
    4. Holster H,
    5. Einarsson S,
    6. Zhang X,
    7. et al.
    Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci U S A 2008;105:12979–84.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Kondo Y,
    2. Shen L,
    3. Cheng AS,
    4. Ahmed S,
    5. Boumber Y,
    6. Charo C,
    7. et al.
    Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 2008;40:741–50.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Roman AC,
    2. Benitez DA,
    3. Carvajal-Gonzalez JM,
    4. Fernandez-Salguero PM
    . Genome-wide B1 retrotransposon binds the transcription factors dioxin receptor and Slug and regulates gene expression in vivo. Proc Natl Acad Sci U S A 2008;105:1632–7.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Roman AC,
    2. Gonzalez-Rico FJ,
    3. Molto E,
    4. Hernando H,
    5. Neto A,
    6. Vicente-Garcia C,
    7. et al.
    Dioxin receptor and SLUG transcription factors regulate the insulator activity of B1 SINE retrotransposons via an RNA polymerase switch. Genome Res 2011;21:422–32.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Lunyak VV,
    2. Prefontaine GG,
    3. Nunez E,
    4. Cramer T,
    5. Ju BG,
    6. Ohgi KA,
    7. et al.
    Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis. Science 2007;317:248–51.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Beck CR,
    2. Collier P,
    3. Macfarlane C,
    4. Malig M,
    5. Kidd JM,
    6. Eichler EE,
    7. et al.
    LINE-1 retrotransposition activity in human genomes. Cell 2010;141:1159–70.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Ewing AD,
    2. Kazazian HH Jr.
    . High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res 2010;20:1262–70.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Huang CR,
    2. Schneider AM,
    3. Lu Y,
    4. Niranjan T,
    5. Shen P,
    6. Robinson MA,
    7. et al.
    Mobile interspersed repeats are major structural variants in the human genome. Cell 2010;141:1171–82.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Iskow RC,
    2. McCabe MT,
    3. Mills RE,
    4. Torene S,
    5. Pittard WS,
    6. Neuwald AF,
    7. et al.
    Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 2010;141:1253–61.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Molecular Cancer Research: 10 (10)
October 2012
Volume 10, Issue 10
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
SINE Retrotransposons Cause Epigenetic Reprogramming of Adjacent Gene Promoters
(Your Name) has forwarded a page to you from Molecular Cancer Research
(Your Name) thought you would be interested in this article in Molecular Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
SINE Retrotransposons Cause Epigenetic Reprogramming of Adjacent Gene Promoters
Marcos R.H. Estécio, Juan Gallegos, Mhair Dekmezian, Yue Lu, Shoudan Liang and Jean-Pierre J. Issa
Mol Cancer Res October 1 2012 (10) (10) 1332-1342; DOI: 10.1158/1541-7786.MCR-12-0351

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
SINE Retrotransposons Cause Epigenetic Reprogramming of Adjacent Gene Promoters
Marcos R.H. Estécio, Juan Gallegos, Mhair Dekmezian, Yue Lu, Shoudan Liang and Jean-Pierre J. Issa
Mol Cancer Res October 1 2012 (10) (10) 1332-1342; DOI: 10.1158/1541-7786.MCR-12-0351
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • GRM1 Suppression in Human Melanoma Cells
  • Genomic Targets and Role in Cell Survival of AEBP1
Show more Cancer Genes and Genomics
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement